APPLICATION OF METHOD BASED ON IN VITRO ANTIBODY QUANTIFICATION IN PBMC SUPERNATANT SAMPLES FOR IMMUNOGENICITY EVALUATION OF A (H5N1) AND A (H5N2) POTENTIALLY PANDEMIC INFLUENZA VA...

por I. V. Losev, S. A. Donina, G. D. Petukhova, M. K. Erofeeva, L. G. Rudenko, A. N. Naykhin
Publicado 2016

Comparative efficacy and safety of preventive treatment with cytovir-3 and arbidol in children during seasonal outbreak of respiratory viral infection (an open-label randomized cli...

por V. S. Smirnov, S. A. Saveliev, S. V. Petlenko, G. Redlich, M. K. Erofeeva, A. V. Lyovina, N. I. Zavialova
Publicado 2019

INDUCTION OF LONG-TERM T AND B CELL MEMORY IMMUNITY TO INFLUENZA A VIRUS (H5N1) IN PERSONS VACCINATED WITH LIVE INFLUENZA A VACCINE (H5N2)

por I. V. Losev, S. A. Donina, G. D. Petukhova, D. A. Korenkov, M. K. Erofeeva, M. A. Stukova, L. G. Rudenko, A. N. Naykhin
Publicado 2017

CLINICAL TRIAL OF THE PANDEMIC INFLUENZA MONOVALENT VACCINE PANDEFLU

por M. K. Erofeeva, V. L. Maksakova, I. Y. Nickonorov, M. G. Pozdnyakova, O. S. Kotova, E. A. Okhapkina, V. D. Evgrafov, E. M. Voicehovskaya, A. A. Vasilyeva, M. A. Stukova, D. S. Bushmenkov, A. A. Romanova, O. I. Kiselev
Publicado 2014